Biomarin Pharmaceutical (BMRN) Q1 2026 Earnings

23FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.28
0.22
0.73
1.23

Details

Expected EPS
0.169417
Actual EPS
-0.24
Surprise EPS
-0.41
Surprise Percent
+241.66%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.24 per share for Q1 2026.

0 Comments

Share your thoughts